Skip to Main Content

Author Details

Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
1994
283
71
PMIDPaper TitleJournal TitlePublished Year
37724942Novel NCOA2/3-rearranged low-grade fibroblastic spindle cell tumors: A report of five cases.Genes Chromosomes Cancer2024
37999736The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.Virchows Arch2024
37724942Novel NCOA2/3-rearranged low-grade fibroblastic spindle cell tumors: A report of five cases.Genes Chromosomes Cancer2024
37999736The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.Virchows Arch2024
35922263Undetected KIT and PDGFRA mutations: an under-recognised cause of gastrointestinal stromal tumours (GISTs) incorrectly classified as wild-type.Pathology2023
36107728The capillary lobule variant of radiation-associated angiosarcoma in the setting of breast cancer: A diagnostic pitfall.J Cutan Pathol2023
36214810Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.J Infect Dis2023
36074249Superficial low-grade fibromyxoid sarcoma.J Cutan Pathol2023
36073677Dataset for reporting of gastrointestinal stromal tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR).Histopathology2023
35922263Undetected KIT and PDGFRA mutations: an under-recognised cause of gastrointestinal stromal tumours (GISTs) incorrectly classified as wild-type.Pathology2023
37593416Complete loss of <i>TP53</i> and <i>RB1</i> is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma.HGG Adv2023
37345731The spectrum and significance of secondary (co-occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis.J Pathol2023
36709077Therapeutic targeting of TEAD transcription factors in cancer.Trends Biochem Sci2023
36567163Primary cutaneous extraskeletal osteosarcoma: a series of 16 cases.Pathology2023
37260142Incidence, demographics, and survival of malignant hemangioendothelioma in the United States.Cancer Med2023
37310519Intra-host mutation rate of acute SARS-CoV-2 infection during the initial pandemic wave.Virus Genes2023
37111340Leveraging Hot Spots of TEAD-Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling.Pharmaceuticals (Basel)2023
36598859Loss of CDKN2A Cooperates with WWTR1(TAZ)-CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma.Clin Cancer Res2023
37593416Complete loss of <i>TP53</i> and <i>RB1</i> is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma.HGG Adv2023
37345731The spectrum and significance of secondary (co-occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis.J Pathol2023
37310519Intra-host mutation rate of acute SARS-CoV-2 infection during the initial pandemic wave.Virus Genes2023
37111340Leveraging Hot Spots of TEAD-Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling.Pharmaceuticals (Basel)2023
37260142Incidence, demographics, and survival of malignant hemangioendothelioma in the United States.Cancer Med2023
36709077Therapeutic targeting of TEAD transcription factors in cancer.Trends Biochem Sci2023
36567163Primary cutaneous extraskeletal osteosarcoma: a series of 16 cases.Pathology2023
36598859Loss of CDKN2A Cooperates with WWTR1(TAZ)-CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma.Clin Cancer Res2023
36214810Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.J Infect Dis2023
36074249Superficial low-grade fibromyxoid sarcoma.J Cutan Pathol2023
36073677Dataset for reporting of gastrointestinal stromal tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR).Histopathology2023
36107728The capillary lobule variant of radiation-associated angiosarcoma in the setting of breast cancer: A diagnostic pitfall.J Cutan Pathol2023
34736340Molecular Pathogenesis of Gastrointestinal Stromal Tumor: A Paradigm for Personalized Medicine.Annu Rev Pathol2022
36046749Adjuvant Radiation after Primary Resection of Atypical Lipomatous Tumors of the Extremity Reduces Local Recurrence but Increases Complications: A Multicenter Evaluation.Sarcoma2022
35449398Machine learning for rhabdomyosarcoma histopathology.Mod Pathol2022
35578013Correction to: Machine learning for rhabdomyosarcoma histopathology.Mod Pathol2022
35443056The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras-MAPK Signaling in Epithelioid Hemangioendothelioma.Clin Cancer Res2022
36006773Pleomorphic Liposarcoma: A Series of 120 Cases With Emphasis on Morphologic Variants.Am J Surg Pathol2022
35740643Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma.Cancers (Basel)2022
35417479Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex.PLoS One2022
36577525Whole-genome characterization of myoepithelial carcinomas of the soft tissue.Cold Spring Harb Mol Case Stud2022
34736340Molecular Pathogenesis of Gastrointestinal Stromal Tumor: A Paradigm for Personalized Medicine.Annu Rev Pathol2022
34968506A clinicopathologic analysis of 54 cases of cutaneous myxoma.Hum Pathol2022
34996885Synchronous Occurrence of Advanced Gastric Carcinoma with Retroperitoneal Liposarcoma: A Case Report.Am J Case Rep2022
35740643Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma.Cancers (Basel)2022
35443056The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras-MAPK Signaling in Epithelioid Hemangioendothelioma.Clin Cancer Res2022
35578013Correction to: Machine learning for rhabdomyosarcoma histopathology.Mod Pathol2022
35417479Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex.PLoS One2022
35449398Machine learning for rhabdomyosarcoma histopathology.Mod Pathol2022
36577525Whole-genome characterization of myoepithelial carcinomas of the soft tissue.Cold Spring Harb Mol Case Stud2022
36046749Adjuvant Radiation after Primary Resection of Atypical Lipomatous Tumors of the Extremity Reduces Local Recurrence but Increases Complications: A Multicenter Evaluation.Sarcoma2022
36006773Pleomorphic Liposarcoma: A Series of 120 Cases With Emphasis on Morphologic Variants.Am J Surg Pathol2022
  • 1 - 50 of 566

Recommended Authors

Lina Irshaid
Pathology Associates at Beverly Hospital
Career Start Year 2017
Number of shared co-authors 1
Kentaro Ohara
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 8
Yun-Shao Sung
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 25
Dina Halai
Royal National Orthopaedic Hospital National Health Service Trust
Career Start Year 2010
Number of shared co-authors 18
Lei Zhang
Guangzhou Kingmed Center for Clinical Laboratory
Career Start Year 2009
Number of shared co-authors 27
Cristiane M Ida
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 3
Somak Roy
University of Cincinnati College of Medicine
Career Start Year 2007
Number of shared co-authors 8
Julio A Diaz-Perez
12235University of Miami Miller School of Medicine
Career Start Year 2007
Number of shared co-authors 2
Arun S Singh
University of California-Los Angeles
Career Start Year 2006
Number of shared co-authors 6
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 10
Noah Federman
University of California los angeles
Career Start Year 2001
Number of shared co-authors 8
Fausto J Rodriguez
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 8
Jilong Yang
Tianjin Medical University Cancer Institute and Hospital
Career Start Year 2000
Number of shared co-authors 3
Paul Fr??neaux
Institut Curie
Career Start Year 1999
Number of shared co-authors 4
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 0
Angela C Hirbe
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 7
Jaime Ferrer
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 0
Sara O Vargas
Boston Children's Hospital
Career Start Year 1997
Number of shared co-authors 8
Fernanda Amary
Royal National Orthopaedic Hospital
Career Start Year 1997
Number of shared co-authors 26
Franck Tirode
Cancer Center of Lyon
Career Start Year 1997
Number of shared co-authors 12
Gonzague de Pinieux
University Hospital of Tours
Career Start Year 1996
Number of shared co-authors 3
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 17
Roberto Tirabosco
University College London, UCL Cancer Institute
Career Start Year 1994
Number of shared co-authors 26
Scott D Nelson
University of California-Los Angeles
Career Start Year 1990
Number of shared co-authors 3
Pedram Argani
The Johns Hopkins Hospital
Career Start Year 1987
Number of shared co-authors 15
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 5
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 8
Takanori Hirose
Hyogo Cancer Center
Career Start Year 1984
Number of shared co-authors 1
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 14
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 19

Collaborators

Charles Keller
Children's Cancer Therapy Development Institute
Co-authored papers 27
Christopher L Corless
Oregon Health & Science University
Co-authored papers 22
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 16
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 15
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 15
Joel E Michalek
University of Texas Health Science Center
Co-authored papers 15
Suresh I Prajapati
Co-authored papers 14
Jinu Abraham
Oregon Health & Science University
Co-authored papers 11
Koichi Nishijo
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers 9
Lee Ann Zarzabal
University of Texas Health Science Center
Co-authored papers 8
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Andre M Oliveira
Mayo Clinic
Co-authored papers 8
Amanda T McCleish
Co-authored papers 8
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Co-authored papers 7
Charlotte K Y Ng
University of Bern
Co-authored papers 7
Salvatore Piscuoglio
University of Basel
Co-authored papers 6
Markku Miettinen
National Cancer Institute
Co-authored papers 6
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Andrew E Rosenberg
Co-authored papers 6
Cristina R Antonescu
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Ken Kikuchi
Kyoto Prefectural University of Medicine
Co-authored papers 6
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Ilan Weinreb
University Health Network
Co-authored papers 5
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 5
Gianrico Farrugia
Mayo Clinic Gastroenterology and Hepatology, Mayo Clinic
Co-authored papers 4
Atiya Mansoor
Oregon Health & Science University
Co-authored papers 4
Eri Taniguchi
Kyoto University
Co-authored papers 4
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Luciano G Martelotto
Monash University
Co-authored papers 4
Release 1.2